REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
11.07
-0.26 (-2.29%)
Aug 18, 2026, 4:00 PM EDT - Market closed
REGENXBIO Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 174.48 | 170.44 | 83.33 | 90.24 | 112.72 | 470.35 |
Revenue Growth | 12.00% | 104.54% | -7.66% | -19.94% | -76.03% | 204.30% |
Gross Profit Gross Profit Growth | -78.42 | -78.16 | -158.76 | -176.24 | -184.27 | 237.08 |
Operating Income Operating Income Growth | -164.15 | -161.2 | -231.25 | -264.43 | -255.38 | 159.98 |
Net Income Net Income Growth | -196.43 | -193.88 | -227.1 | -263.49 | -280.32 | 127.84 |
Earnings Per Share EPS Growth | -3.77 | -3.76 | -4.59 | -6.02 | -6.50 | 2.91 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 42.61 | 30 | 28.88 | 39.45 | 32.92 |
Japan Japan Growth | 74.99 | - | - | - | - |
Germany Germany Growth | - | 8.33 | - | 11.27 | - |
United Arab Emirates United Arab Emirates Growth | - | 8.33 | - | - | - |
Foreign Foreign Growth | 52.84 | 36.66 | 61.36 | 62 | 65.85 |
Total Total Growth | 170.44 | 83.33 | 90.24 | 112.72 | 470.35 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 105.52 | 240.85 | 244.87 | 314.13 | 565.2 | 849.35 |
Total Debt Total Debt Growth | 250.46 | 260.52 | 141.72 | 183.34 | 232.41 | 258.03 |
Net Cash (Debt) Net Cash Growth | -144.95 | -19.66 | 103.15 | 130.79 | 332.8 | 591.32 |
Net Cash Growth | - | - | -21.13% | -60.70% | -43.72% | 130.45% |
Net Cash Per Share Net Cash Per Share Growth | -2.78 | -0.38 | 2.08 | 2.99 | 7.71 | 13.47 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -246.67 | -123.96 | -173.13 | -218.41 | -207.49 | 218.88 |
Capital Expenditures CapEx Growth | -2.99 | -2.41 | -2.44 | -9.96 | -30.72 | -84.18 |
Free Cash Flow Free Cash Flow Growth | -249.67 | -126.38 | -175.56 | -228.37 | -238.21 | 134.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -44.95% | -45.86% | -190.53% | -195.29% | -163.47% | 50.41% |
Operating Margin | -94.08% | -94.58% | -277.51% | -293.02% | -226.55% | 34.01% |
Pretax Margin | -112.58% | -113.75% | -272.54% | -292.15% | -248.75% | 30.03% |
Profit Margin | -112.58% | -113.75% | -272.54% | -291.99% | -248.68% | 27.18% |
FCF Margin | -143.09% | -74.15% | -210.69% | -253.06% | -211.32% | 28.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 10.94 |
Forward PE | - | 35.95 | 54.68 | 54.68 | 54.68 | 76.17 |
P/FCF Ratio | - | - | - | - | - | 10.38 |
PS Ratio | 4.19 | 4.28 | 4.60 | 8.75 | 8.71 | 2.97 |